LUIS MARÍA GARCÍA DE GUADIANA ROMUALDO

Cerezo Manchado JJ, Iturbe Hernandez T, Martinez Pacheco MDC, Gil Ortega I, Campoy D, Canals Pernas T, Martinez Serra L, Flores Aparco KJ, Velasquez Escandon CA, Garcia de Guadiana-Romualdo L, Martinez Frances A, Olivera P. Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the "ACO-VID" Registry. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231208440. doi: 10.1177/10760296231208440. PubMed PMID: 37899606; PubMed Central PMCID: PMC10617267.

AÑO: 2023; IF: 2.9

37899606

Rodriguez Rojas C, Garcia de Guadiana-Romualdo L, Moran Sanchez S, Prazak J, Algara Soriano V, Que YA, Benninga R, Albaladejo-Oton MD. Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis. Dig Dis Sci. 2022 Jul;67(7):3275-3283. doi: 10.1007/s10620-021-07152-6. Epub 2021 Jul 15. PubMed PMID: 34268662.

AÑO: 2022; IF: 3.1

34268662

Garcia de Guadiana-Romualdo L, Diaz Lopez MI, Crespo Alvarez E, Martinez Manzano A, Urrechaga E, Orgaz Morales MT. Usefulness of the extended inflammatory parameters related to neutrophil activation reported on Sysmex XN-1000 haematology analyser as indicators of acute appendicitis: comparison with canonical inflammatory laboratory tests. Scand J Clin Lab Invest. 2022 Oct;82(6):492-494. doi: 10.1080/00365513.2022.2116726. Epub 2022 Sep 1. No abstract available. PubMed PMID: 36047910.

AÑO: 2022; IF: 2.1

36047910

Cerezo-Manchado JJ, Meca Birlanga O, Garcia de Guadiana Romualdo L, Gil-Ortega I, Martinez Frances A, Iturbe-Hernandez T. Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocol. Drugs Context. 2022 Jan 24;11:2021-9-4. doi: 10.7573/dic.2021-9-4. eCollection 2022. PubMed PMID: 35145555; PubMed Central PMCID: PMC8798364.

AÑO: 2022

35145555

Garcia de Guadiana-Romualdo L, Rodriguez Rojas C, Morell-Garcia D, Andaluz-Ojeda D, Rodriguez Mulero MD, Rodriguez-Borja E, Ballesteros-Vizoso A, Calvo MD, Albert-Botella L, Pozo Giraldez A, Llompart-Alabern I, Bolado Jimenez C, Hernandez Olivo M, Fernandez Presa L, Ortega-Perez J, Fora Romero MJ, Campos-Rodriguez V, Ballester Ferriz A, Guiu-Marti AM, Pinilla Arribas L, Galindo Martinez M, Puerto-Lara ER, Lopez Tarazaga AB, Ros Braquehais MS, Nogales Martin L, Juez Santamaria C, Trapiello Fernandez W, Espinilla Fernandez V, Havelka A, Albaladejo-Oton MD. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study). Inflamm Res. 2022 Jan;71(1):57-67. doi: 10.1007/s00011-021-01516-4. Epub 2021 Oct 30. PubMed PMID: 34718856; PubMed Central PMCID: PMC8556860.

AÑO: 2022; IF: 6.7

34718856